|
|
||||||||
RENAL HEMODYNAMICS AND CARDIORENAL INTEGRATION
Departamento de Fisiologia, Pontificia Universidad Catolica de Chile, Santiago, Chile
Submitted 11 January 2006 ; accepted in final form 20 July 2006
Recovery from acute renal failure (ARF) requires the replacement of injured cells with new cells that restore tubule epithelial integrity. We described recently the expression of a wide range of nephrogenic proteins in tubular cells after ARF induced by ischemia-reperfusion (I/R) (Villanueva S, Cespedes C, and Vio CP. Am J Physiol Regul Integr Comp Physiol 290: R861R870, 2006). These markers, namely, Vimentin, neural cell adhesion molecules (Ncam), basic fibroblast growth factor (bFGF), paired homeobox-2 (Pax-2), bone morphogene protein-7 (BMP-7), Noggin, Lim-1, Engrailed, Smad, phospho-Smad, hypoxia-induced factor-1
(HIF-1
), VEGF, and Tie-2, are expressed in a time frame similar to that observed in normal kidney development. bFGF participates in early kidney development as a morphogen involved in mesenchyme/epithelial transition, and it is reexpressed in the recovery phase of ARF. To test the hypothesis that bFGF can accelerate the regeneration after renal damage, we used recombinant bFGF and studied the expression pattern of the above described morphogens in ARF. Male Sprague-Dawley rats were subjected to 30 min of renal ischemic injury and were injected with bFGF 30 µg/kg followed by reperfusion. Rats were killed and the expression of nephrogenic proteins were analyzed by immunohistochemistry and Western blot analysis. In the animals subjected to I/R treated with bFGF, we observed a 12- to 24-h earlier and more abundant reexpression of the proteins Ncam, bFGF, Pax-2, BMP-7, Noggin, Lim-1, Engrailed, VEGF, and Tie-2 than the I/R untreated rats. In addition, we observed a reduction in renal damage markers ED-1 and
-smooth muscle actin. These results indicate that bFGF can participate in the regeneration process and suggest that the treatment with bFGF can induce an earlier regeneration process after ischemic acute renal failure.
kidney; morphogen; regeneration
This article has been cited by other articles:
![]() |
R. Vasko, M. Koziolek, M. Ikehata, M. P. Rastaldi, K. Jung, H. Schmid, M. Kretzler, G. A. Muller, and F. Strutz Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1452 - F1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Basile, K. Fredrich, B. Chelladurai, E. C. Leonard, and A. R. Parrish Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor Am J Physiol Renal Physiol, April 1, 2008; 294(4): F928 - F936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Villanueva, C. Cespedes, A. A. Gonzalez, E. Roessler, and C. P. Vio Inhibition of bFGF-receptor type 2 increases kidney damage and suppresses nephrogenic protein expression after ischemic acute renal failure Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R819 - R828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhuang, G. R. Kinsey, K. Rasbach, and R. G. Schnellmann Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells Am J Physiol Renal Physiol, March 1, 2008; 294(3): F459 - F468. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Lash Epidermal growth factor receptor ligands and renal epithelial cell proliferation Am J Physiol Renal Physiol, March 1, 2008; 294(3): F457 - F458. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |